INDSWFTLAB

Ind-Swift Laboratories Limited

IN Healthcare Drug Manufacturers - Specialty & Generic

Latest week
10 Jul 2026
Close
246.440002
Fair value
112.538654
Next-week expectancy
Undecided 49.93%
Sharemaestro

INDSWFTLAB Chart Pack

Ind-Swift Laboratories Limited

Exchange
NSI
Latest week
10 Jul 2026
Close
246.440002
Fair value
112.538654
Next-week expectancy
Undecided 49.93%
Generated
16 Jul 2026 16:30
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, INDSWFTLAB rose 79.36%, moving from 137.40 to 246.44. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 101.95 and has improved across the 12-week window. Market Dynamics is 1.45 on the latest week. Next-week expectancy is undecided at 49.93% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
246.44
12-Week Change
79.36%
Trend Signal
Active
Next-Week Expectancy
Undecided 49.93%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
101.95
Market Dynamics
1.45

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
246.44
12-Week Change
79.36%
Trend Signal
Active
Next-Week Expectancy
Undecided 49.93%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
101.95
Market Dynamics
1.45

Over the latest 12 completed weeks ending 2026-07-10, INDSWFTLAB rose 79.36%, moving from 137.40 to 246.44. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 101.95 and has improved across the 12-week window. Market Dynamics is 1.45 on the latest week. Next-week expectancy is undecided at 49.93% based on similar historical setup states.

Industry Peers

India equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
UNICHEMLAB Unichem Laboratories Limited NSI 10 Jul 2026 475.95 687.20 454.05 638.75 34.21%
RPGLIFE RPG Life Sciences Limited NSI 10 Jul 2026 2392.16 2889.00 2362.45 2856.90 19.43%
IOLCP IOL Chemicals and Pharmaceuticals Limited NSI 10 Jul 2026 143.70 177.90 143.00 171.06 19.04%
BETA BETA DRUGS LIMITED NSI 10 Jul 2026 2109.00 2395.00 1980.00 2366.80 12.22%
AKUMS AKUMS DRUGS AND PHARMA L NSI 10 Jul 2026 630.00 707.40 620.00 701.95 11.42%
HIKAL Hikal Limited NSI 10 Jul 2026 221.98 247.50 215.00 244.75 10.26%
SPARC Sun Pharma Advanced Research Company Limited NSI 10 Jul 2026 241.00 289.00 241.00 264.60 9.79%
SUVEN Suven Life Sciences Limited NSI 10 Jul 2026 327.60 370.80 308.50 357.85 9.23%
PGHL Procter & Gamble Health Limited NSI 10 Jul 2026 6371.00 6941.00 6202.50 6839.00 7.35%
GRANULES Granules India Limited NSI 10 Jul 2026 839.50 901.80 834.50 889.85 6.00%
INDOCO Indoco Remedies Limited NSI 10 Jul 2026 246.00 265.09 234.10 260.23 5.78%
ORCHPHARMA Orchid Pharma Limited NSI 10 Jul 2026 964.80 1075.50 916.75 1012.55 4.95%
NATCOPHARM NATCO Pharma Limited NSI 10 Jul 2026 940.00 997.30 919.90 984.10 4.69%
AMANTA AMANTA HEALTHCARE LIMITED NSI 10 Jul 2026 171.24 189.00 171.24 179.17 4.63%
ABBOTINDIA Abbott India Limited NSI 10 Jul 2026 26070.00 27350.00 26025.00 27165.00 4.20%
BLISSGVS Bliss GVS Pharma Limited NSI 10 Jul 2026 504.96 535.45 469.33 524.30 3.83%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.